A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
Max R. O’Donnell(Columbia University Irving Medical Center), W. Ian Lipkin(Columbia University), Thomas Briese(Columbia University), Nischay Mishra(Institute of Infection and Immunity), Beatriz Grinsztejn(University of Maryland, Baltimore), Matthew J. Cummings(NewYork–Presbyterian Hospital), Lokendra V. Chauhan(Institute of Infection and Immunity), Stephen A. Ferrara(Columbia University Irving Medical Center), Leon Claude Sidi(Hospital Federal dos Servidores do Estado), Dawn Scotto(Columbia University Irving Medical Center), Steven L. Spitalnik(Columbia University), Alex Kantor(Columbia University Irving Medical Center), Maria Pia Diniz(Instituto Evandro Chagas), AG Vizzoni(Instituto Evandro Chagas), Zachary C. Bitan(Columbia University Irving Medical Center), Flavia Dei Zotti(Columbia University Irving Medical Center), Vinay Gupta(University of Birmingham), Andrew Eisenberger, Jessica Justman(Columbia University Irving Medical Center), Brie A. Stotler(Columbia University Irving Medical Center), Joseph E. Schwartz(Stony Brook School), José Henrique Pilotto(Universidade Iguaçu), Beth H. Shaz(New York Blood Center), Sandeep N. Wontakal(Columbia University Irving Medical Center), Sarah Borden(Columbia University Irving Medical Center), Francesca La Carpia(Presbyterian Hospital), Neena M. Philip(Columbia University), Ying Kuen Cheung(Columbia University), Sandra Wagner Cardoso(Instituto Evandro Chagas), Elizabeth F. Stone(Columbia University Irving Medical Center), Darryl Abrams(Columbia University Irving Medical Center), Wen-Hsuan W. Lin(Columbia University Irving Medical Center), Valdiléa G. Veloso, Esaú João(Hospital Federal dos Servidores do Estado), Eldad A. Hod(Presbyterian Hospital), Matthew R. Lamb(Columbia University), Benjamin J. Meyer(Columbia University), Allison Wolf(Columbia University Irving Medical Center), Samuel D. Jacobson(Columbia University), C. Eckhardt(Columbia University Irving Medical Center), Kartik Rajagopalan(The University of Texas Southwestern Medical Center), Krystalyn E. Hudson(Columbia University)
Cited by 172
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives
|Circulation|2003|1.2k
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
|The Lancet|2011|999
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863